comparemela.com

Page 4 - Nasdaq Phvs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Short Interest in Pharvaris (NASDAQ:PHVS) Drops By 47 6%

Pharvaris (NASDAQ:PHVS – Get Free Report) was the recipient of a significant decrease in short interest in June. As of June 30th, there was short interest totalling 18,900 shares, a decrease of 47.6% from the June 15th total of 36,100 shares. Approximately 0.2% of the company’s stock are short sold. Based on an average trading […]

Short Interest in Pharvaris (NASDAQ:PHVS) Decreases By 44 4%

Pharvaris (NASDAQ:PHVS – Free Report) was the target of a large drop in short interest during the month of June. As of June 15th, there was short interest totalling 36,100 shares, a drop of 44.4% from the May 31st total of 64,900 shares. Based on an average daily volume of 28,900 shares, the short-interest ratio […]

Pharvaris Announces $70 Million Private Placement

ZUG, Switzerland, June 20, 2023 (GLOBE NEWSWIRE) Pharvaris (Nasdaq: PHVS), a clinical-stage company focused on the development and commercialization.

Analysts Set Pharvaris (NASDAQ:PHVS) Price Target at $16 50

Pharvaris (NASDAQ:PHVS – Get Rating) has earned a consensus recommendation of “Moderate Buy” from the six research firms that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company. The average […]

Pharvaris (NASDAQ:PHVS) Given Consensus Rating of Moderate Buy by Analysts

Pharvaris (NASDAQ:PHVS – Get Rating) has been given an average recommendation of “Moderate Buy” by the six analysts that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have given a buy recommendation to the company. The average […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.